Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
The effects of receiving radiotherapy once a day for 6.5 weeks or twice a day for 3 weeks among people with small cell lung cancer has been compared in a clinical trial.
Researchers found that the two treatment methods were equally effective among people with small cell lung cancer that has not spread.
The study was presented at the American Society of Clinical Oncology conference yesterday (Sunday 5 June, 2016).
547 people from around the world took part in the study. Half of participants received radiotherapy twice a day for 3 weeks, while the other half received it once a day at a higher dose for 6.5 weeks. All participants also received chemotherapy.
People who went through the 3-week, twice-daily treatment option were found to have similar survival rates and side effects to those on the 6.5 week, once-daily course of treatment. However, the researchers noted that those on the shorter, more frequent course were more likely to experience weakening of the immune system (74% of participants, compared to 65% in the other group).
The researchers believe that this finding could open up opportunities for people with small cell lung cancer to decide on the best treatment route with their healthcare professionals.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
No description